| Period Ending | Feb 1, 2013 | Oct 26, 2012 | Jul 27, 2012 | Apr 27, 2012 |
|---|
|
Total Revenue
|
1,468,531
|
1,169,649
|
951,407
|
921,218
| | Cost of Revenue | 554,155 | 438,082 | 357,000 | 344,859 | | |
Gross Profit
|
914,376
|
731,567
|
594,407
|
576,359
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 685,826 | 619,170 | 567,443 | 570,037 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
228,550
|
112,397
|
26,964
|
6,322
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 228,550 | 112,397 | 26,964 | 6,322 |
|
Interest Expense | 3,069 | 1,583 | 1,547 | 1,089 |
|
Income Before Tax | 225,481 | 110,814 | 25,417 | 5,233 |
|
Income Tax Expense | 78,481 | 39,307 | 9,898 | 2,248 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 147,000 | 71,507 | 15,519 | 2,985 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
147,000
|
71,507
|
15,519
|
2,985
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
147,000
|
71,507
|
15,519
|
2,985
|
|
0.12(0.22%) 10:53AM EDT - Nasdaq Real Time Price